Quite frankly I don’t think the delay in uplisting to the NASDAQ has anything to do with timing the announcement or waiting for the EUA, nor short activity. My belief is the NASDAQ wants to see whatever board change commits Cytodyn made actually happen after the settlement regarding over compensation for the execs. Even though many of the shares were clawed back, the optics of this was bad. There isn’t any other way to slice it. You don’t raid the cookie jar and then have either the NYSE or NASDAQ blow that off as nothing. And remember, Mullholland always says you can checks the boxes but it’s up to the NaSDAQs discretion to uplist you. So whatever board changes need to be made need to happen to make sure this doesn’t happen again.